SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is experiencing sustained momentum driven by a growing community focused on celebrating cannabis culture and the plant's medicinal potential. Enthusiasts are actively coordinating to build a long-term presence on-chain, emphasizing the project's steady progress and the anticipation surrounding the annual 4/20 cultural milestones.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is drawing significant attention as investors react to a strategic acquisition and persistent rumors of potential partnerships, with community sentiment fueled by the stock's high volatility and strong correlation to Bitcoin's price action. While some traders are focused on a potential short squeeze or a broader institutional re-rating, others remain cautious, debating the long-term impact of share dilution and the company's ability to execute on its pivot toward stablecoin settlement and institutional infrastructure.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is experiencing intense community focus as traders speculate on its potential for human identity verification and its role in an increasingly AI-driven digital economy. The conversation is heavily centered on its utility as a 'Proof of Personhood' solution and the impact of recent treasury initiatives and institutional interest surrounding the project.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is gaining significant momentum as investors pivot toward its long-term potential as an AI and energy-infrastructure company rather than just an EV manufacturer. The community is actively discussing the company's recent expansion of its battery-swapping network and its strategic move into self-developed AI chips, with many looking toward upcoming vehicle delivery milestones as a key catalyst to drive the share price through current resistance levels.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending amid intense market volatility driven by regional conflict in the Middle East and concerns over the stability of the Strait of Hormuz. The community is actively debating the impact of potential supply disruptions against the backdrop of broader economic uncertainty, with traders sharply divided between bullish expectations for continued energy price spikes and bearish concerns regarding aggressive market manipulation and speculative bubbles.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining significant traction as a key infrastructure provider in the DeFi space, with community sentiment fueled by its role in the Real World Asset (RWA) narrative and its integration of institutional-grade financial data. Investors are actively discussing the protocol's revenue-sharing model through token buybacks and its unique utility in supplying government-validated macroeconomic data to blockchain ecosystems.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is trending as the broader market grapples with extreme volatility driven by the escalating conflict in Iran, which has sparked fears over oil supply and global shipping routes. Investors are closely monitoring erratic signals from the Trump administration regarding the conflict and energy supply, while debating the long-term economic impacts of rising inflation and geopolitical instability.

Vanguard Malvern Funds - Vanguard Short-Term Inflation-Protected Securities Index Fund

Vanguard Short-Term Inflation-Protected Securities ETF

VTIP is currently trending as investors seek protection against rising inflation, with market participants actively debating the effectiveness of short-term TIPS ETFs as a hedge against economic volatility. Community discussions center on the interplay between persistent inflationary pressures and the broader bond market, as investors look for ways to safeguard purchasing power amidst shifting economic conditions.

FIS Trust - FIS Christian Stock Shares of beneficial interest

SHP ETF Trust - FIS Biblically Responsible Risk Managed ETF

Investors are actively debating the intersection of personal faith and portfolio management, with many sharing scripture and reflections on ethical investing within the PRAY ETF community. While some participants are discussing the fund's alignment with their values, others are using the platform as a space to share personal motivations for market participation and conservative lifestyle principles.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is trending as investors aggressively hedge against heightened geopolitical risks, including escalating tensions with Iran and uncertainty surrounding new trade tariff policies. The community is actively debating the volatility ETF's structural decay, with many traders using it as a tactical tool to capitalize on daily market swings and anticipated macro-economic shocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BTIG Research Reaffirms "Buy" Rating for AC Immune (NASDAQ:ACIU)

BTIG Research reissued a "buy" rating and set a $8.00 price target on shares of AC Immune in a report on Monday...

AC Immune (NASDAQ:ACIU) Given Average Recommendation of "Hold" by Brokerages

Shares of AC Immune (NASDAQ:ACIU - Get Free Report) have been assigned an average rating of "Hold" from the five analysts that are currently covering the firm, MarketBeat reports. One analyst has...

AC Immune (NASDAQ:ACIU) Issues Earnings Results, Beats Estimates By $0.01 EPS

AC Immune (NASDAQ:ACIU - Get Free Report) released its earnings results on Friday. The company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of...

AC Immune (ACIU) Projected to Post Quarterly Earnings on Thursday

AC Immune (NASDAQ:ACIU) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...

AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised AC Immune from a "sell" rating to a "hold" rating in a research note on Saturday...

AC Immune (NASDAQ:ACIU) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of AC Immune from a "hold" rating to a "sell" rating in a research note on Saturday...

AC Immune (NASDAQ:ACIU) Stock Price Down 5.4% - Time to Sell?

AC Immune (NASDAQ:ACIU) Trading Down 5.4% - Here's Why...

Short Interest in AC Immune (NASDAQ:ACIU) Grows By 94.4%

AC Immune (NASDAQ:ACIU - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 3,593,227...

AC Immune (NASDAQ:ACIU) Trading Up 5% - Should You Buy?

AC Immune (NASDAQ:ACIU) Trading 5% Higher - Here's What Happened...

<ul class="summary-bullets"><li>The trial results showed for the first time that active immunotherapy targeting a-syn pathology could slow the progression of Parkinson’s disease.&nbsp;</li><li>The interim results from the study showed a 100% responder rate for all targets.</li><li>ACIU plans to seek regulatory feedback to potentially speed up the clinical development path towards registration.&nbsp; &nbsp;</li></ul>AC Immune SA (ACIU) shares surged on Thursday morning after the biopharma company announced positive results from the interim Phase 2 study of its early Parkinson’s disease treatment.&nbsp;The company said that the results of the VacSYn trial of ACI-7104.056 showed, for the first time, that targeting a-syn pathology with an active immunotherapy could possibly slow the progression of Parkinson’s disease.&nbsp;Shares of&nbsp;<a href="https://stocktwits.com/symbol/ACIU">ACIU</a> surged over 23% in pre-market trading after the announcement.&nbsp;“The interim Phase 2 data shows the potential of our ACI-7104.056 active immunotherapy to slow the progression of Parkinson’s disease and hold the promise of a tremendous step forward for millions of patients,” said Andrea Pfeifer, CEO of AC Immune SA. Pfeifer added that the strong results would be a basis for accelerating the development of the treatment.&nbsp;<h2 class="st-heading-2">Study Results</h2>The interim results from the study showed that the company’s new treatment had a 100% responder rate, meaning all participants had the expected immune response across all immunogenicity measures used.There were no clinically relevant or serious adverse effects to the drug apart from routine side effects such as injection site reactions, headaches, and fatigue, as reported by some participants.&nbsp;Final results from the Part 1 trial are expected in mid-2026, and the company plans to seek regulatory feedback to potentially speed up the clinical development path towards registration.&nbsp;<h2 class="st-heading-2">How Are Stocktwits Users Reacting?</h2>On Stocktwits, retail sentiment around ACIU jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume jumped to ‘extremely high’ from ‘normal’ levels at the time of writing.<figure class="image"><img style="aspect-ratio:1282/158;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_11_at_7_36_27_PM_png_161653af50.webp" alt="ACIU sentiment and message volume" width="1282" height="158"></figure>Shares of ACIU are up over 31% in the past six months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CHINA - 2025/10/02: In this photo illustration, the AC Immune logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Is AC Immune Stock Up Over 23% Today?

ACIU shares surged over 23% after the company announced positive results from an interim Phase 2 study. 

Equity

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

ACIU
AC Immune SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ACIU News

ACIUAC Immune SA